These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7545074)

  • 1. Structure-based drug design ten years on.
    Robertus J
    Nat Struct Biol; 1994 Jun; 1(6):352-4. PubMed ID: 7545074
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus).
    Itoh S; Navia MA
    Protein Sci; 1995 Nov; 4(11):2261-8. PubMed ID: 8563622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovering high-affinity ligands for proteins: SAR by NMR.
    Shuker SB; Hajduk PJ; Meadows RP; Fesik SW
    Science; 1996 Nov; 274(5292):1531-4. PubMed ID: 8929414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases.
    Kay JE
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):361-85. PubMed ID: 8670043
    [No Abstract]   [Full Text] [Related]  

  • 5. Consensus preferred hydration sites in six FKBP12-drug complexes.
    Faerman CH; Karplus PA
    Proteins; 1995 Sep; 23(1):1-11. PubMed ID: 8539241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antascomicins A, B, C, D and E. Novel FKBP12 binding compounds from a Micromonospora strain.
    Fehr T; Sanglier JJ; Schuler W; Gschwind L; Ponelle M; Schilling W; Wioland C
    J Antibiot (Tokyo); 1996 Mar; 49(3):230-3. PubMed ID: 8626235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical modification of rapamycin: the discovery of SDZ RAD.
    Sedrani R; Cottens S; Kallen J; Schuler W
    Transplant Proc; 1998 Aug; 30(5):2192-4. PubMed ID: 9723437
    [No Abstract]   [Full Text] [Related]  

  • 8. Developmental expression of FK506 binding proteins and calcineurin in rat brain.
    Charters AR; Kobayashi M; Butcher SP
    Biochem Soc Trans; 1995 Aug; 23(3):422S. PubMed ID: 8566310
    [No Abstract]   [Full Text] [Related]  

  • 9. Nuclear magnetic resonance methods for studying protein-ligand complexes.
    Petros AM; Fesik SW
    Methods Enzymol; 1994; 239():717-39. PubMed ID: 7530321
    [No Abstract]   [Full Text] [Related]  

  • 10. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex.
    Kissinger CR; Parge HE; Knighton DR; Lewis CT; Pelletier LA; Tempczyk A; Kalish VJ; Tucker KD; Showalter RE; Moomaw EW
    Nature; 1995 Dec; 378(6557):641-4. PubMed ID: 8524402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophilins, ligands, and the control of signal transduction.
    Schreiber SL; Crabtree GR
    Harvey Lect; 1995-1996; 91():99-114. PubMed ID: 9127988
    [No Abstract]   [Full Text] [Related]  

  • 12. The 37 kDa immunophilin has uracil DNA glycosylase but not rotamase activity.
    Goodyear N; Murthy JN; Soldin SJ
    Clin Biochem; 1997 Aug; 30(6):497-9. PubMed ID: 9316745
    [No Abstract]   [Full Text] [Related]  

  • 13. FK506-binding protein mutational analysis: defining the active-site residue contributions to catalysis and the stability of ligand complexes.
    DeCenzo MT; Park ST; Jarrett BP; Aldape RA; Futer O; Murcko MA; Livingston DJ
    Protein Eng; 1996 Feb; 9(2):173-80. PubMed ID: 9005438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from molecular matchmakers.
    Teague S
    Nat Struct Biol; 1995 May; 2(5):360-1. PubMed ID: 7545076
    [No Abstract]   [Full Text] [Related]  

  • 15. Droplet discovery.
    Sikorski R; Peters R
    Science; 1998 Jan; 279(5349):412-3. PubMed ID: 9454334
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure-based design of novel, urea-containing FKBP12 inhibitors.
    Dragovich PS; Barker JE; French J; Imbacuan M; Kalish VJ; Kissinger CR; Knighton DR; Lewis CT; Moomaw EW; Parge HE; Pelletier LA; Prins TJ; Showalter RE; Tatlock JH; Tucker KD; Villafranca JE
    J Med Chem; 1996 Apr; 39(9):1872-84. PubMed ID: 8627611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein matchmaker may lead new gene therapy to the altar.
    Balter M
    Science; 1996 Jul; 273(5272):183. PubMed ID: 8668994
    [No Abstract]   [Full Text] [Related]  

  • 18. Three-dimensional structure of the immunophilin-like domain of FKBP59 in solution.
    Craescu CT; Rouvière N; Popescu A; Cerpolini E; Lebeau MC; Baulieu EE; Mispelter J
    Biochemistry; 1996 Aug; 35(34):11045-52. PubMed ID: 8780506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 32-Ascomycinyloxyacetic acid derived immunosuppressants. Independence of immunophilin binding and immunosuppressive potency.
    Wagner R; Rhoades TA; Or YS; Lane BC; Hsieh G; Mollison KW; Luly JR
    J Med Chem; 1998 May; 41(11):1764-76. PubMed ID: 9599228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An automated method for dynamic ligand design.
    Miranker A; Karplus M
    Proteins; 1995 Dec; 23(4):472-90. PubMed ID: 8749844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.